Safety, Tolerability, Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Naïve Patients With Chronic HBV Infection
Conditions
- Hepatitis B
- Chronic Hepatitis B Atypical
Interventions
- DRUG: IONIS-HBVRx
- DRUG: Placebo
Sponsor
GlaxoSmithKline
Collaborators